Intercept Announces Phase 3 REVERSE Trial Evaluating OCA for the Treatment of NASH Patients Pharmaceutical Investing
Isodiol International Inc. Announces Partnership With Europe’s Leading MMA Promotion, Cage Warriors; ISO-Sport Product Line to Commence Sales in the European Market Biotech Investing
Clinical Study on Phivida’s Nano-CBD™ at the University of Nottingham (UK) in Collaboration with Artelo Biosciences, Inc. Cannabis Investing News
Pieris Pharmaceuticals and Seattle Genetics Announce Multi-Program Immuno-Oncology Collaboration Pharmaceutical Investing
Pacific Biosciences Announces Outcome of First Phase of Patent Litigation Against Oxford Nanopore Genetics Investing
Catalyst Biosciences Announces Positive Top-Line Data from Phase 1/2 Study of Subcutaneous CB Biotech Investing
Immunomedics Announces Second Quarter Fiscal 2018 Results and Provides Corporate Update Biotech Investing
Abeona Therapeutics Reports Top-Line Data from Phase 1/2 Gene Therapy Trial in MPS IIIA Pharmaceutical Investing
